Skip to content


Your cart is empty

Webinar | Medication Safety During COVID-19: What Have We Learned?


ismp logo

From the shifting of infusion pumps to outside of patient rooms to the use of unproven medications for both the prophylaxis and treatment of COVID-19, medication safety changes have been necessary to protect staff and support patients during the SARS-CoV-2 pandemic. But were these methods successful? What can be done better? How do these applications impact the future of medication safety?

Join ECRI and the Institute of Safe Medication Practices (ISMP) experts as they sit down with front-line medication safety practitioners to learn how and why these and other changes were made. Speakers share essential learnings about the implications of these changes and discuss where we go from here to monitor medication safety moving forward.

Webinar recording

Agenda & Speakers


Michael R. Cohen, RPh, MS, ScD, FASHP

President, ISMP

Christina Michalek, BS, RPh, FASHP

Medication Safety Specialist, ISMP


Andrew S. Martin, MSN, RN, CPHRM

Patient Safety Analyst/Consultant III, ECRI

Steven Meisel, PharmD

Director of Patient Safety, Fairview Health Services

Paul Milligan, PharmD

System Medication Safety Pharmacist BJC HealthCare